Cellebrite
CLBT
209 hedge funds and large institutions have $1.89B invested in Cellebrite in 2025 Q2 according to their latest regulatory filings, with 43 funds opening new positions, 85 increasing their positions, 60 reducing their positions, and 33 closing their positions.
175% more call options, than puts
Call options by funds: $3.99M | Put options by funds: $1.45M
42% more repeat investments, than reductions
Existing positions increased: 85 | Existing positions reduced: 60
30% more first-time investments, than exits
New positions opened: 43 | Existing positions closed: 33
5% more funds holding
Funds holding: 199 → 209 (+10)
2.85% more ownership
Funds ownership: 46.45% → 49.3% (+2.8%)
13% less capital invested
Capital invested by funds: $2.16B → $1.89B (-$272M)
50% less funds holding in top 10
Funds holding in top 10: 14 → 7 (-7)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
T. Rowe Price Investment Management
Baltimore,
Maryland
|
+$60.3M |
| 2 |
Millennium Management
New York
|
+$26.3M |
| 3 |
VC
Voss Capital
Houston,
Texas
|
+$23.3M |
| 4 |
ACH
ArrowMark Colorado Holdings
Denver,
Colorado
|
+$22.5M |
| 5 |
Capital Research Global Investors
Los Angeles,
California
|
+$22.1M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
-$67.1M |
| 2 |
CC
Crosslink Capital
Menlo Park,
California
|
-$27.3M |
| 3 |
Acadian Asset Management
Boston,
Massachusetts
|
-$24.7M |
| 4 |
DCM
Driehaus Capital Management
Chicago,
Illinois
|
-$20.1M |
| 5 |
Connor, Clark & Lunn Investment Management (CC&L)
Vancouver,
British Columbia, Canada
|
-$11.3M |
CLBT Hedge Fund Activity: Q2 2025 in Review
209 of the 7,613 institutional investors tracked by Wall St. Rank reported a position in Cellebrite (CLBT) for Q2 2025, worth a combined $1.89B — down 13% from $2.16B a quarter earlier.
Buyers outnumbered sellers: 43 funds opened new CLBT positions and 33 closed out — a net gain of 10 holders — while 85 added to existing stakes and 60 trimmed.
The largest buyer was T. Rowe Price Investment Management, adding an estimated $60.3M. The largest seller was Fidelity Investments, cutting an estimated $67.1M.
- 209 institutional investors held Cellebrite (CLBT) as of Q2 2025, up from 199 in Q1 2025.
- Funds reported $1.89B of Cellebrite stock for Q2 2025, down 13% quarter-over-quarter.
- 43 funds opened new Cellebrite positions in Q2 2025 and 33 closed out, a net change of +10 holders.
- The largest Cellebrite buyer in Q2 2025 was T. Rowe Price Investment Management, an estimated $60.3M added.
- The largest Cellebrite seller in Q2 2025 was Fidelity Investments, an estimated $67.1M sold.
Based on aggregated 13F filings for Q2 2025.